NCT00023036

Brief Summary

This study will try to identify and understand the genetic factors that lead to an inner ear malformation called "enlarged vestibular aqueducts", that can be associated with hearing loss. Patients with sensorineural hearing loss with or without inner ear malformations and their parents and siblings may be eligible for this study. Participants and their immediate family members, may undergo some or all of the following tests and procedures:

  • Medical and family history, including questions about hearing, balance and other ear-related issues, and review of medical records.
  • Routine physical examination.
  • Blood draw or buccal swab (brushing inside the cheek to collect cells) - Tissue is collected for DNA analysis to look for changes in genes that may be related to hearing loss.
  • Hearing tests - The subject listens for tones emitted through a small earphone.
  • Balance test (VEMP) to see if balance functions of the inner ear are associated with the hearing loss Electrodes will be placed behind your ear and at the base of your neck. From a reclining position, you will be asked to raise your head while clicking sounds are played into your ears. - Ultrasound tests - An inner ear malformation called EVA (enlargement of the vestibular aqueduct) indicates that a genetic disorder called Pendred syndrome may be the cause. Because thyroid abnormalities are also associated with Pendred syndrome, an ultrasound examination of the thyroid gland may be done.
  • Computed tomography (CT) and magnetic resonance imaging (MRI) scans - These tests show the structure of the inner ear. For CT, the subject lies still for a short time while X-ray images are obtained. For MRI, the patient lies on a stretcher that is moved into a cylindrical machine with a strong magnetic field. The magnetic field and radio waves produce images of the inner ear. The radio waves cause loud thumping noises that can be muffled by the use of earplugs.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
324

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 21, 2001

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 22, 2001

Completed
13 days until next milestone

Study Start

First participant enrolled

September 4, 2001

Completed
Last Updated

May 1, 2026

Status Verified

February 2, 2026

First QC Date

August 21, 2001

Last Update Submit

April 30, 2026

Conditions

Keywords

GeneticsDeafnessGenetic MarkersGenetic AnalysisGENETIC LINKAGENatural HistoryHearing ImpairmentNonsyndromic Hereditary Hearing ImpairmentSNHLInner EarEnlarged Vestibular AqueductsEVA

Outcome Measures

Primary Outcomes (1)

  • By using genetic linkage, identify and map possible additional mutant alleles of SLC26A4 or other genes causing nonsyndromic EVA in patients with one or no detectable mutant allele of SLC26A4

    Identify genes other than SLC26A4 that cause EVA.

    ongoing

Study Arms (4)

1

Patients with known or suspected nonsyndromic SNHL associated with EVA

2

Patients with nonsyndromic EVA

3

unaffected siblings and parents of affected family members

4

Other unaffected relatives; included if there is more than one sibship with affected family

Eligibility Criteria

AgeUp to 99 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Affected and non-affected family members and affected single sporadic subjects with sensorineural hearing loss and enlarged vestibular aqueducts.

You may qualify if:

  • Subjects must have or be a family member of a participant with known or non-syndromic SNHL associated with EVA or have evidence of other findings that suggest that EVA might be part of a novel phenotype
  • There must be at least two participating affected family members with one exception: if there is only one participating affected family member, there must be genetic test results identifying only one pathogenic mutant allele of SLC26A4
  • Adults must be able to provide informed consent
  • Minors must have a parent or guardian able to provide consent
  • Age between 0-99.

You may not qualify if:

  • Subjects with known exposure to physical or chemical teratogens in utero that could account for their inner ear malformations such as thalidomide or radiation
  • Any hearing loss that is associated with symptoms which meet the criteria of already known syndromes, such as, branchio-oto-renal (BOR) syndrome, which comprises system malformations and branchial cleft abnormalities and is caused by heterozygous mutations in the EYA1 gene.
  • Previous genetic testing identifying two pathogenic mutant alleles of SLC26A4.
  • Prospective study subjects who are cognitively impaired and lack consent capacity, will not be enrolled.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States

Location

Related Publications (3)

  • Bauman NM, Kirby-Keyser LJ, Dolan KD, Wexler D, Gantz BJ, McCabe BF, Bale JF Jr. Mondini dysplasia and congenital cytomegalovirus infection. J Pediatr. 1994 Jan;124(1):71-8. doi: 10.1016/s0022-3476(94)70256-x.

    PMID: 8283378BACKGROUND
  • Dahle AJ, Fowler KB, Wright JD, Boppana SB, Britt WJ, Pass RF. Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol. 2000 May;11(5):283-90.

    PMID: 10821506BACKGROUND
  • Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M, Adawi F, Hazani E, Nassir E, Baxevanis AD, Sheffield VC, Green ED. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet. 1997 Dec;17(4):411-22. doi: 10.1038/ng1297-411.

    PMID: 9398842BACKGROUND

Related Links

MeSH Terms

Conditions

Hearing Loss, SensorineuralCytomegalovirus InfectionsDeafnessHearing LossNonsyndromic sensorineural hearing loss

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsHerpesviridae InfectionsDNA Virus InfectionsVirus DiseasesInfections

Study Officials

  • Thomas B Friedman, Ph.D.

    National Institute on Deafness and Other Communication Disorders (NIDCD)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Time Perspective
PROSPECTIVE
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 21, 2001

First Posted

August 22, 2001

Study Start

September 4, 2001

Last Updated

May 1, 2026

Record last verified: 2026-02-02

Locations